Germany's vaccine advisory committee updated its guidance on Monday to recommend that all children and adolescents aged 12-17 be given a COVID-19 vaccine, citing further safety data and increased risks posed by the more infectious Delta variant.
Britain's medicines regulator said on Friday it had approved the COVID-19 vaccine developed by Pfizer (PFE.N) and BioNTech (22UAy.DE)for use on 12- to 15-year-olds, following similar clearances in the U.S. and the E.U.